867256-73-3

Basic information

• Product Name: (R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine
• Synonyms: (R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine
• CAS NO: 867256-73-3
• Molecular Formula: C₁₀H₂₀N₂
• Molecular Weight: 168.2792
• Mol File: 867256-73-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 228.1°C at 760 mmHg
• Flash Point: 80.7°C
• Appearance: /
• Density: 0.944g/cm3
• Vapor Pressure: 0.0749mmHg at 25°C
• Refractive Index: 1.486
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine(867256-73-3)
• EPA Substance Registry System: (R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine(867256-73-3)

Safety Data

• Hazardous Substances Data: 867256-73-3(Hazardous Substances Data)

Usage

General Description

(R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine is a chemical compound consisting of two pyrrolidine rings connected by a methyl group. The compound is chiral, with one of the pyrrolidine rings being in the (R) configuration and the other in the (S) configuration. It is commonly used in organic synthesis and pharmaceutical research as a building block for creating complex molecules. The compound has been studied for its potential biological activity and has shown promise in certain pharmacological applications. Additionally, its chiral nature may also make it useful in asymmetric synthesis and as a chiral auxiliary in stereoselective reactions. Overall, (R)-2-methyl-1-((S)-pyrrolidin-2-ylmethyl)pyrrolidine is a versatile compound with potentially valuable applications in various fields of chemistry and biology.

InChI:InChI=1/C10H20N2/c1-9-4-3-7-12(9)8-10-5-2-6-11-10/h9-11H,2-8H2,1H3

Upstream product

• 1379448-37-9 (2(R)-methyl-pyrrolidin-1-yl)-pyrrolidin-2-yl-methanone 

Downstream Products

• 867256-82-4 [2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-methanone 

Relevant articles and documents

NOVEL BETULINIC SUBSTITUTED AMIDE DERIVATIVES AS HIV INHIBITORS

The present invention relates to novel betulinic substituted amide compounds of formula (I); and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, X, Y, Z1, Z2, Z3 and are Formula (II) as defined herein. The invention novel betulinic substituted amide derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

The present invention provides a novel compound of Formula (I) or a pharmaceutically acceptable salt thereof, having histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another, embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods and intermediates for preparing such compounds. In anot